A Quality of Life and Chart Review of Patients Living with Treatment Resistant Major Depressive Disorder at a Single Site in Australia

Not Applicable

Completed

• Conditions: Treatment Resistant Depression; Mental Health - Depression

• Registration Number: ACTRN12621000297820
• Lead Sponsor: Janssen-Cilag Pty Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-18
• Study Completion: 2022-04-12
• Last Update Posted: 19 September 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Patients with major depressive disorder experiencing a depressive episode as defined by clinical judgment AND with treatment resistant depression (major depressive disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current depressive episode).

Exclusion Criteria

1.Patients with diminished capacity for decision making in the opinion of the investigator
2.Patients under 18 years of age
3.Patients not fluent in English

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life in people with TRD experiencing depressive episode will be assessed using the AQoL-8D.[At the time of once off survey]

Secondary Outcome Measures

Name	Time	Method
Severity of depression and clinical characteristics of TRD patients will be assessed using the HAM-D and a semi-structured interview.[At the time of once off survey]